See more : GMO GlobalSign Holdings K.K. (3788.T) Income Statement Analysis – Financial Results
Complete financial analysis of Alvotech (ALVOW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alvotech, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Hisar Spinning Mills Limited (HISARSP.BO) Income Statement Analysis – Financial Results
- Ambow Education Holding Ltd. (AMBO) Income Statement Analysis – Financial Results
- SHRADDHA PRIME PROJECTS LTD (SHRADDHA.BO) Income Statement Analysis – Financial Results
- SINOMACH HEAVY EQUIPMENT GROUP CO.,LTD (601399.SS) Income Statement Analysis – Financial Results
- RPC, Inc. (RES) Income Statement Analysis – Financial Results
Alvotech (ALVOW)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.alvotech.com
About Alvotech
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 91.43M | 83.03M | 36.77M | 66.62M | 31.92M |
| Cost of Revenue | 160.86M | 64.10M | 0.00 | 0.00 | 0.00 |
| Gross Profit | -69.42M | 18.93M | 36.77M | 66.62M | 31.92M |
| Gross Profit Ratio | -75.93% | 22.80% | 100.00% | 100.00% | 100.00% |
| Research & Development | 210.83M | 180.62M | 191.01M | 148.07M | 95.56M |
| General & Administrative | 76.56M | 186.74M | 84.13M | 58.91M | 48.57M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 76.56M | 186.74M | 84.13M | 58.91M | 48.57M |
| Other Expenses | -1.95M | -1.99M | -2.91M | -2.83M | -50.76M |
| Operating Expenses | 285.44M | 365.38M | 272.23M | 204.15M | 93.37M |
| Cost & Expenses | 446.46M | 429.47M | 272.23M | 204.15M | 93.37M |
| Interest Income | 4.82M | 2.55M | 51.57M | 215.00K | 1.74M |
| Interest Expense | 134.82M | 188.42M | 117.36M | 97.47M | 95.76M |
| Depreciation & Amortization | 24.21M | 20.41M | 18.20M | 16.42M | 14.61M |
| EBITDA | -484.86M | -439.80M | 3.99M | -125.67M | -99.02M |
| EBITDA Ratio | -530.29% | -392.72% | -457.17% | -188.65% | -150.74% |
| Operating Income | -354.86M | -346.44M | -235.46M | -137.54M | -61.45M |
| Operating Income Ratio | -388.11% | -417.25% | -640.31% | -206.46% | -192.52% |
| Total Other Income/Expenses | -296.19M | -205.21M | 86.26M | -154.23M | -147.94M |
| Income Before Tax | -651.05M | -551.65M | -149.20M | -291.77M | -209.39M |
| Income Before Tax Ratio | -712.04% | -664.40% | -405.74% | -437.99% | -656.01% |
| Income Tax Expense | -99.32M | -38.07M | -47.69M | -121.73M | 491.00K |
| Net Income | -551.73M | -513.58M | -101.50M | -170.04M | -209.88M |
| Net Income Ratio | -603.42% | -618.55% | -276.04% | -255.26% | -657.55% |
| EPS | -2.43 | -2.60 | -3.25 | -5.44 | -0.86 |
| EPS Diluted | -2.43 | -2.60 | -3.25 | -5.44 | -0.86 |
| Weighted Avg Shares Out | 227.26M | 197.72M | 31.25M | 31.25M | 243.65M |
| Weighted Avg Shares Out (Dil) | 227.26M | 197.72M | 31.25M | 31.25M | 243.65M |
No news found for: ALVOW
Source: https://incomestatements.info
Category: Stock Reports